Physician profile
Manish S Parikh
NPI 1730120668
$22,436.81
in general payments reported to CMS, 2019-2025
22 companies · $4,124 in 2025
The $4,124 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,669 · 2020: $761 · 2021: $3,195 · 2022: $2,882 · 2023: $1,281 · 2024: $1,526 · 2025: $4,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,131 · Consulting Fee: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,130.73 |
| Consulting Fee | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $6,470.14 | 2019-2021 | |
| Abbott Laboratories | $5,620.05 | 2019-2025 | Dragonfly Opstar, Esprit, Navitor |
| Medtronic, INC. | $2,875.17 | 2021-2025 | Signia, Ligasure, Rapidvac |
| Opsens INC. | $2,059.96 | 2019 | |
| Terumo Medical Corporation | $1,929.63 | 2025 | Metacross Otw |
| Siemens Medical Solutions USA, INC. | $1,083.28 | 2019-2022 | |
| Abiomed | $402.06 | 2019-2021 | |
| Shockwave Medical, INC | $327.09 | 2021-2022 | |
| Allergan, INC. | $279.82 | 2021-2022 | |
| Covidien Lp | $251.81 | 2019-2020 | |
| Cardiovascular Systems INC. | $250.25 | 2019 | |
| Asahi Intecc USA, INC. | $180.18 | 2025 | Asahi Peripheral Vascular Wires |
| Olympus America INC. | $142.52 | 2023 | Olympus |
| Surmodics, INC. | $136.37 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Janssen Pharmaceuticals, INC | $91.61 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $84.86 | 2019 | |
| Gilead Sciences, INC. | $76.44 | 2019 | |
| Intuitive Surgical, INC. | $59.57 | 2023 | |
| Recor Medical INC | $40.55 | 2024 | Paradise Renal Denervation System |
| Amgen INC. | $37.70 | 2020-2023 | Repatha |
| Kowa Pharmaceuticals America, INC. | $19.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.